{"transactions":[{"id":1377024,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-04T21:06:07.000Z","date":"2024-10-31","kind":"sale","planned":false,"acquired":false,"shares":3080,"price":16.625,"value":51205.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":69140,"source":{"system":"sec-edgar","filing":"0001140361-24-045101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124045101/form4.xml","form_type":"4"}},{"id":1457448,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-09T20:05:18.000Z","date":"2024-07-08","kind":"sale","planned":false,"acquired":false,"shares":3026,"price":20.395,"value":61715.27,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":72220,"source":{"system":"sec-edgar","filing":"0001140361-24-032761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124032761/form4.xml","form_type":"4"}},{"id":1543633,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-11T00:39:37.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":12532,"price":24.638,"value":308763.416,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":75226,"source":{"system":"sec-edgar","filing":"0001140361-24-019167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124019167/form4.xml","form_type":"4"}},{"id":1628580,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T01:54:22.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":32727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 32,727 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":32727,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":32727},"source":{"system":"sec-edgar","filing":"0001140361-24-008887","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008887/form4.xml","form_type":"4"}},{"id":1628579,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:22.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":11096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"shares","element":"transactionShares","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":87758,"source":{"system":"sec-edgar","filing":"0001140361-24-008887","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008887/form4.xml","form_type":"4"}},{"id":1920850,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T23:00:22.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":57739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 57,739 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":57739,"derivative":{"exercise_price":17.41,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":57739},"source":{"system":"sec-edgar","filing":"0001140361-23-018047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123018047/form4.xml","form_type":"4"}},{"id":1920849,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":86339,"kind":"person","name":"White Mark Andrew","position":1,"cik":"0001973240","reported_name":"White Mark Andrew","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2023-04-12T23:00:22.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":76662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 4, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":76662,"source":{"system":"sec-edgar","filing":"0001140361-23-018047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123018047/form4.xml","form_type":"4"}}]}